CTLA-4 polymorphisms and systemic lupus erythematosus (SLE): a meta-analysis

Area of Science:

• Immunogenetics
• Autoimmune Diseases
• Genetic Epidemiology

Background:

• Cytotoxic T lymphocyte antigen-4 (CTLA-4) is implicated in immune dysregulation and autoimmunity.
• Previous studies on CTLA-4 gene variants and systemic lupus erythematosus (SLE) susceptibility have yielded inconsistent results.
• CTLA-4 is a key regulator of T-cell activation and a candidate gene for autoimmune disease susceptibility.

Purpose of the Study:

• To conduct a meta-analysis to clarify the association between CTLA-4 gene polymorphisms and SLE susceptibility.
• To evaluate the influence of specific CTLA-4 polymorphic sites on SLE risk.
• To assess ethnic differences in the association between CTLA-4 variants and SLE.

Main Methods:

• Meta-analysis of 14 independent studies investigating CTLA-4 polymorphisms and SLE.
• Comparison of allele and genotype frequencies at four polymorphic sites: exon-1 (+49), promoter (-318, -1722), and 3'UTR (dinucleotide repeat).
• Application of fixed and random effect models based on inter-study heterogeneity.

Main Results:

• The CTLA-4 exon-1 +49 polymorphism is significantly associated with SLE susceptibility.
• The exon-1 +49 GG genotype shows an overall increased risk (OR=1.287, P=0.011).
• This association is particularly pronounced in Asian populations (OR=1.293, P=0.026) and shows a similar trend in Europeans, though not statistically significant.

Conclusions:

• The CTLA-4 exon-1 +49 (A/G) polymorphism contributes to the risk of developing SLE.
• The findings suggest a significant role for this polymorphism in SLE pathogenesis, especially among Asian individuals.
• This meta-analysis provides robust evidence supporting the link between CTLA-4 exon-1 +49 and SLE risk.